Stay updated on Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1. The page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-10T15:47:39.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a minimal header and a Home link, indicating the requested study page is currently inaccessible.
    Difference
    0.5%
    Check dated 2026-09-26T16:48:04.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the previous trial content. This prevents viewing trial details, eligibility criteria, and related materials on the page.
    Difference
    19%
    Check dated 2026-09-19T18:11:32.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, indicating a minor update to the ClinicalTrials.gov study page. This change does not modify any study details or visible content.
    Difference
    0.1%
    Check dated 2026-08-29T20:50:30.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5 on the page, indicating a new version of the ClinicalTrials.gov record. This reflects an internal update to the page rather than changes to study details or results.
    Difference
    0.1%
    Check dated 2026-08-08T18:19:25.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4, signaling a new release of the page template or tooling; there are no visible content changes to the study details.
    Difference
    0.1%
    Check dated 2026-07-25T10:46:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.